Golden State Wealth Management »

Aligos Therapeutics shares owned by Golden State Wealth Management

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Golden State Wealth Management from 13F filings

Historical chart of Golden State Wealth Management investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Golden State Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Golden State Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $107k 2.7k 39.84

More positions owned by Golden State Wealth Management

Ishares Core MF Closed and MF Open (IVV)
Apple Common Stock (AAPL)
Ishares Core MF Closed and MF Open (AGG)
First Trust MF Closed and MF Open (FVD)
Invesco Qqq MF Closed and MF Open (QQQ)
Amazon Common Stock (AMZN)
Hsbc Long MF Closed and MF Open (WINN)
Spdr Portfolio MF Closed and MF Open (SPAB)
Nvidia Corp Common Stock (NVDA)
SPDR S&P MF Closed and MF Open (SPY)
Principal Us MF Closed and MF Open (USMC)
First Trust MF Closed and MF Open (FTCS)
Alphabet Common Stock (GOOGL)
Blackstone Common Stock (BX)
Microsoft Corp Common Stock (MSFT)

View all positions for Golden State Wealth Management

Top funds holding Aligos Therapeutics

Armistice Capital
EcoR1 Capital
Deep Track Capital
Adage Capital Partners GP
Vivo Capital
Woodline Partners
Baker Bros. Advisors
Hillhouse Capital Advisors
UBS O'Connor
Vanguard Group
Acadian Asset Management
Silverarc Capital Management
Geode Capital Management
Drive Wealth Management
Renaissance Technologies

View all funds holding Aligos Therapeutics